<DOC>
	<DOC>NCT02792517</DOC>
	<brief_summary>A pharmacokinetic drug interaction study of AMG 334 and an oral contraceptive containing progestin and estrogen.</brief_summary>
	<brief_title>AMG 334 Plus Combined Oral Contraceptive Drug Interaction Study in Healthy Females</brief_title>
	<detailed_description>A pharmacokinetic drug interaction study of AMG 334 and an oral contraceptive containing progestin and estrogen. Approximately 35 subjects will be enrolled. All subjects will receive an oral contraceptive containing progestin and estrogen throughout the duration of the study. Subjects will also receive a single dose of AMG 334, administered by a healthcare provider. Serial PK samples will be collected at specified time points to characterize PK of an oral contraceptive containing progestin and estrogen with and without the presence of AMG 334.</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Contraceptives, Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Contraceptives, Oral, Combined</mesh_term>
	<mesh_term>Progestins</mesh_term>
	<criteria>Healthy female ≥18 to ≤45 years old at the time of enrollment Regular monthly menstrual cycle during the last 12 months Good general health based on a medical history evaluation and physical examination No clinically significant abnormalities in laboratory tests at screening Subject has provided informed consent/assent prior to initiation of any study specific activities/procedures Intolerance to any recent oral contraceptive in the last three (3) years, Female subjects with a positive serum pregnancy test at screening Female subjects not willing to inform her sexual partner of her participation in the clinical study Use of any over the counter or prescription medications within the 14 days or 5 half lives (whichever is longer) Nicotine use eg cigarettes or equivalent during 12 months prior to day 1 and through the duration of the study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>